2024年11月7日,用于癌症检测的医疗科技公司Guardant Health(股票代码:GH)盘前大涨31.2%,引起了市场广泛关注。在没有重大事件公告的情况下,分析师机构发布的利好评级成为推动该股大涨的主要原因。
根据分析师报告,Guardant Health的液体活检技术在医疗检测领域处于领先地位,加上疫情影响减弱,预计该公司未来几年业绩将继续保持高速增长。多家机构上调了Guardant Health的评级和目标价,包括摩根大通将目标价从48美元上调至50美元,Leerink Partners则将目标价从50美元上调至60美元。分析师普遍看好该公司前景。
与此同时,一些其他行业公司也因良好的业绩预期而获得分析师的利好评级,推动当天股价走高。但在缺乏重大事件驱动的情况下,Guardant Health股价如此大涨仍属罕见。分析师评级变动或许只是短期原因,该股后市走势还有待进一步观察。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.